Involvement of Bile Acid Metabolism and Gut Microbiota in the Amelioration of Experimental Metabolism-Associated Fatty Liver Disease by Nobiletin

Involvement of Bile Acid Metabolism and Gut Microbiota in the Amelioration of Experimental Metabolism-Associated Fatty Liver Disease by Nobiletin

Metabolism-associated fatty liver disease (MAFLD), a growing health problem worldwide, is one of the major risks for the development of cirrhosis and liver cancer. Oral administration of nobiletin (NOB), a natural citrus flavonoid, modulates the gut microbes and their metabolites in mice. In the pre...

Full description

Bibliographic Details
Main Authors: Hongling Xu, Mingming Yuan, Kailin Niu, Wei Yang, Maoyuan Jiang, Lei Zhang, Jing Zhou
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Molecules
Subjects:
nobiletin
bile acid
gut microbiota
farnesoid X receptor
metabolism-associated fatty liver disease
Online Access:https://www.mdpi.com/1420-3049/29/5/976

Internet

https://www.mdpi.com/1420-3049/29/5/976

Similar Items